Literature DB >> 33265933

Extra-Gastric Manifestations of Helicobacter pylori Infection.

Antonietta G Gravina1, Kateryna Priadko1, Paola Ciamarra1, Lucia Granata1, Angela Facchiano1, Agnese Miranda1, Marcello Dallio1, Alessandro Federico1, Marco Romano1.   

Abstract

Helicobacter Pylori (H. pylori) is a Gram-negative flagellated microorganism that has been extensively studied since its first isolation due to its widespread diffusion and association with numerous diseases. While the bacterium is proved to be a causative factor for a number of gastric diseases such as gastritis, gastric adenocarcinoma, and MALT-lymphoma, its role at other gastrointestinal levels and in other systems is being thoroughly studied. In this article, we reviewed the latest published clinical and laboratory studies that investigated associations of H. pylori with hematologic diseases such as Vitamin B12- and iron-deficiency anemia, primary immune thrombocytopenia, and with a number of dermatologic and ophthalmic diseases. In addition, the putative role of the bacterium in inflammatory bowel diseases, esophageal disorders, metabolic, diseases, neurologic diseases and allergy were outlined.

Entities:  

Keywords:  H. pylori; IBD; Parkinson’s disease; allergy; dermatologic manifestations; diabetes mellitus; eosinophilic esophagitis; extra-gastric manifestations; iron deficiency anemia; ophthalmic manifestations; vitamin B12 deficiency anemia

Year:  2020        PMID: 33265933     DOI: 10.3390/jcm9123887

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  13 in total

1.  Prevalence of H. pylori among asymptomatic HIV-positive and negative individuals in Central Ethiopia and efficacy of eradication therapy.

Authors:  Million Getachew Mesfun; Smaranda Gliga; Andre Fuchs; Hans Martin Orth; Andreas Schönfeld; Tom Luedde; Torsten Feldt
Journal:  IJID Reg       Date:  2022-01-19

2.  Influence of In Vitro Gastric Digestion of Olive Leaf Extracts on Their Bioactive Properties against H. pylori.

Authors:  Marisol Villalva; Jose Manuel Silvan; Esperanza Guerrero-Hurtado; Alba Gutierrez-Docio; Joaquín Navarro Del Hierro; Teresa Alarcón-Cavero; Marin Prodanov; Diana Martin; Adolfo J Martinez-Rodriguez
Journal:  Foods       Date:  2022-06-22

3.  Lack of Association Between Helicobacter pylori Infection and the Risk of Thyroid Nodule Types: A Multicenter Case-Control Study in China.

Authors:  Xiao-Song Wang; Xi-Hai Xu; Gang Jiang; Yu-Huan Ling; Tian-Tian Ye; Yun-Wu Zhao; Kun Li; Yu-Ting Lei; Hua-Qing Hu; Ming-Wei Chen; Heng Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-12-14       Impact factor: 5.293

4.  The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors.

Authors:  Yoo Min Han; Jooyoung Lee; Ji Min Choi; Min-Sun Kwak; Jong In Yang; Su Jin Chung; Jeong Yoon Yim; Goh Eun Chung
Journal:  PLoS One       Date:  2021-12-13       Impact factor: 3.240

5.  Non-alcoholic/Metabolic-Associated Fatty Liver Disease and Helicobacter pylori Additively Increase the Risk of Arterial Stiffness.

Authors:  Ji Min Choi; Hyo Eun Park; Yoo Min Han; Jooyoung Lee; Heesun Lee; Su Jin Chung; Seon Hee Lim; Jeong Yoon Yim; Goh Eun Chung
Journal:  Front Med (Lausanne)       Date:  2022-02-25

6.  Seven Days of Bismuth-Based Quadruple Therapy Is as Effective for the First-Line Treatment of Clarithromycin-Resistant Confirmed Helicobacter pylori Infection as 14 Days of Bismuth-Based Quadruple Therapy.

Authors:  Sang-Gon Moon; Chul-Hyun Lim; Hee-Jun Kang; Arum Choi; Sukil Kim; Jung-Hwan Oh
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

7.  Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication.

Authors:  Yi Hu; Xin Xu; Yao-Bin Ouyang; Cong He; Nian-Shuang Li; Chuan Xie; Chao Peng; Zhen-Hua Zhu; Xu Shu; Yong Xie; Nong-Hua Lu; Yin Zhu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-02       Impact factor: 6.073

8.  Rescue Therapies for H. pylori Infection in Italy.

Authors:  Vincenzo De Francesco; Angelo Zullo; Luigi Gatta; Raffaele Manta; Matteo Pavoni; Ilaria Maria Saracino; Giulia Fiorini; Dino Vaira
Journal:  Antibiotics (Basel)       Date:  2021-05-03

9.  The onset of ulcerative colitis upon Helicobacter pylori eradication in a 72-year-old woman: report of a rare case with a 3-year follow-up.

Authors:  J Homolak; M Nikolić; D Potoč; M Živković; D Bakula; I Budimir; I Pavić; D Hrabar; N Ljubičić; D Vražić
Journal:  BMC Gastroenterol       Date:  2021-07-31       Impact factor: 3.067

Review 10.  Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?

Authors:  Gracia M Martin-Nuñez; Isabel Cornejo-Pareja; Mercedes Clemente-Postigo; Francisco J Tinahones
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.